Evidence map›Paper›PMID 34321048›Full record

ArticleTrials2021

Effect of Greenshell

Maryam Abshirini, Jane Coad, Frances M Wolber, Pamela von Hurst, Matthew R Miller, Hong Sabrina Tian, Marlena C Kruger

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Maryam AbshiriniSchool of Health Sciences, College of Health, Massey University, Private Bag 11222, Palmerston North, 4442, New Zealand.
Jane CoadSchool of Food and Advanced Technology, Massey University, Palmerston North, New Zealand.
Frances M WolberSchool of Food and Advanced Technology, Massey University, Palmerston North, New Zealand.
Pamela von HurstSchool of Food and Nutrition, Massey University, Auckland, New Zealand.
Matthew R MillerCawthron Institute, Nelson, New Zealand.
Hong Sabrina TianSanford Ltd., Auckland, New Zealand.
Marlena C KrugerSchool of Health Sciences, College of Health, Massey University, Private Bag 11222, Palmerston North, 4442, New Zealand. M.C.Kruger@massey.ac.nz.
Massey University · NZCawthron Institute · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNew Zealand Greenshell™ mussels (GSM; Perna canaliculus) have recently been shown to decrease cartilage degradation in a rat model of induced metabolic osteoarthritis (MetOA). However, this effect has not been investigated in human subjects. This study aims to determine the effect of GSM powder on biomarkers of cartilage metabolism, bone resorption, and inflammation in New Zealand healthy overweight/obese postmenopausal women who are at early stage or at high risk of OA.

methodFifty overweight or obese (BMI 25-35 kg/m DISCUSSION: This trial will be the first to explore the effects of whole meat GSM powder on cartilage turnover, bone resorption, and inflammation biomarkers in overweight/obese postmenopausal women. The results from this trial will provide evidence on the efficacy of GSM in the prevention of OA.

trial registrationAustralian New Zealand Clinical Trials Registry (ANZCTR) ACTRN12620000413921p . Registration on 27 March 2020.

Indexed as

BivalviaOsteoarthritis, KneeAnimalsAustraliaBiomarkersDouble-Blind MethodFemaleHumansInflammationNew ZealandPostmenopauseRandomized Controlled Trials as TopicRatsBiomarkersBiomarkerGreen-lipped musselGreenshell musselInflammationOsteoarthritis

Identifiers

PMID34321048
PMCPMC8317363
OpenAlexW3120616117

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.